HER2 Tumour Agnostic Virtual Masterclasses
  • Update and educate attendees on the evolution of tumour agnostic indications (non-breast/non-gastric). Learn about HER2 biology, its clinical value and expression on different tumour types
  • Understand the role of the pathologists in diagnostic pathways and explore different tumours journeys
  • Improve pathologists’ capabilities for scoring HER2 in tumour agnostic (non-breast/non-gastric)
×

Thank you! Your message has been sent.

    Get Case Study

    Improving the treatment care of patients with Multiple Myeloma through regular digital connection between International, National Experts and haematologists in Europe

      Get Brochure